Press "Enter" to skip to content

Ureteral Stents Market Overview With Detailed Analysis, Competitive Landscape, Forecast To 2025

Market Scenario

Ureteral Stents Market size is expected to register 6.6% CAGR during the forecast period of 2019 to 2025, with a market value of USD 302.5 Million in 2018.

A ureteral stent is a thin tube inserted into the ureter to prevent or treat an obstruction of the urine flow from the kidney. The length of the stents used in adult patients varies between 24 and 30 cm.

The global ureteral stents market is driven by factors such as the rising prevalence of kidney diseases and the increasing number of kidney transplants.

Additionally, the technological advancements in ureteral stents and the rising adoption of minimally invasive surgeries are anticipated to fuel the market growth.

Browse Sample of the Report @ 

For instance, as per the Global Observatory on Donation and Transplantation, in 2016, 89,823 kidney transplants were done globally. Thus, the rising number of kidney transplants fueling the growth of the market.

Moreover, major companies in the market are involved in strategic acquisitions, collaborations, mergers, and new launches to sustain their position in the market.

 For instance, in February 2017, Cook Medical launched Universa, a soft ureteral stent set, in its streamline percutaneous urinary drainage product line. This helped strengthen its ureteral stents product portfolio.


The global ureteral stents market has been segmented based on type, material, treatment, end users, and region.

The global market, based on type, has been bifurcated into double pigtail ureteral stent and others.

The double pigtail ureteral stent segment is expected to hold a significant share of the market due growing use of double pigtail ureteral stents as it provides a safe and effective method of ensuring urinary drainage.

Based on material, the global market is segmented into metallic stents, polymers stents, and others. The polymers stents segment is expected to hold a major share of the market due to growing use of bioabsorbable stents and technological improvement in ureteral stents.

The market, based on treatment, has been divided into kidney stones, kidney transplants, and others.

The kidney stones treatment is expected to hold a major share in the market due to the increasing prevalence of kidney stones. For example, according to Urology Annals, in 2018, worldwide, prevalence of kidney stones is 7% in adults, which will increase with recurrence rate of 30% within ten years. The incidence of kidney stones is growing globally with an estimated prevalence ranging up to 15%. During their lifetime, approximately 7% of women and 13% of men will develop a kidney stone.

Based on end user, the market is segmented into hospitals, nephrological centers, and ambulatory surgical centers. The hospitals segment is expected to hold a major share in the market due availability of facilities for kidney transplant procedures and availability of expertise in the hospital.

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The ureteral stents market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European ureteral stents market has been sub-divided into Western Europe and Eastern Europe. Western Europe has further been classified into Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

 The ureteral stents market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The ureteral stents market in the Middle East & Africa has been divided into the Middle East and Africa.

Key Players

The Key Players operating in the Global Ureteral Stents Market are Boston Scientific (US), Cook Medical (US), C.R. Bard (US), B. BRAUN (Germany), Olympus (Japan), Coloplast (Denmark), Allium Medical (Israel), Teleflex Incorporated (US), Biomerics (Italy), Medline industries inc. (US), Merit Medical Systems, Inc. (US), and BrightWater Medical (US).

Browse More Details of the Report @